Profile
James Henry Zukin is the founder of Houlihan Lokey, Inc. which was founded in 1972.
He held the title of Director & Senior Managing Director at the company.
Mr. Zukin also founded Houlihan Lokey Capital, Inc. Mr. Zukin's former job was as an Independent Director at Athenex, Inc. from 2017 to 2018.
Mr. Zukin received his undergraduate degree from the University of California, Berkeley and his MBA from Harvard Business School.
Former positions of James Henry Zukin
| Companies | Position | End |
|---|---|---|
| ATHENEXPAR | Director/Board Member | 2018-06-30 |
Houlihan Lokey Capital, Inc.
 Houlihan Lokey Capital, Inc. Investment Banks/BrokersFinance Houlihan Lokey Capital, Inc. is a registered broker/dealer headquartered in Los Angeles, California. The firm was founded in 1996 and they are a subsidiary of Houlihan Lokey, Inc. (NYSE: HLI). Houlihan Lokey Capital provides an array of trading and execution services for their clients. They also have the ability to serve as underwriter or bookrunner with respect to traditional debt and equity offerings, including leveraged loans and public offerings of debt, equity-linked, and equity securities. | Founder | 2014-03-31 |
| HOULIHAN LOKEY, INC. | Founder | - |
Training of James Henry Zukin
| University of California, Berkeley | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HOULIHAN LOKEY, INC. | Finance |
| Private companies | 2 |
|---|---|
Houlihan Lokey Capital, Inc.
Houlihan Lokey Capital, Inc. Investment Banks/BrokersFinance Houlihan Lokey Capital, Inc. is a registered broker/dealer headquartered in Los Angeles, California. The firm was founded in 1996 and they are a subsidiary of Houlihan Lokey, Inc. (NYSE: HLI). Houlihan Lokey Capital provides an array of trading and execution services for their clients. They also have the ability to serve as underwriter or bookrunner with respect to traditional debt and equity offerings, including leveraged loans and public offerings of debt, equity-linked, and equity securities. | Finance |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- James Henry Zukin
